According to data from the U.S. Centers for Disease Control and Prevention, the number of federal government-assigned vaccination shots from Johnson & Johnson Covid-19 is expected to decrease by 84% next week.
Nearly 5 million doses of the Johnson & Johnson vaccine were allotted to states and other jurisdictions this week, but only about 785,000 are planned for next week.
However, the allocation of the Pfizer / BioNTech and Moderna vaccines for next week remains constant compared to this week. For the next week, approximately 4.7 million first doses of Pfizer and 3.5 million first doses of Moderna were allocated along with the corresponding second doses.
The Pfizer / BioNTech and Moderna vaccine assignments were largely consistent from week to week. However, the weekly allocations of the Johnson & Johnson vaccine varied widely.
According to the CDC, the first allocation of the Johnson & Johnson vaccine – for the week of March 1 – comprised more than 2.8 million doses. No Johnson & Johnson vaccine allocations are logged for the week of March 8, and allocations have decreased to less than 500,000 doses for the following two weeks. Then, for the week of March 29, allocations soared to nearly 2 million before more than doubling for that week.
According to the CDC, here are the total weekly allocations for the Johnson & Johnson vaccine to states and other jurisdictions:
- Week of March 1st: 2,833,400
- Week of March 8th: none
- Week of March 15th: 493,700
- Week of March 22nd: 389,900
- Week of March 29th: 1,911,200
- Week of April 5th: 4,947,500
- Week of April 12th: 785,500
According to the latest data from the CDC, about 4.5 million people have been vaccinated with the Johnson & Johnson vaccine, which is about 7% of the people who are fully vaccinated in the United States.